UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011199
Receipt number R000013053
Scientific Title Study of skin properties of children for intradermal vaccine administration
Date of disclosure of the study information 2013/07/17
Last modified on 2014/01/16 16:36:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of skin properties of children for intradermal vaccine administration

Acronym

Study of skin properties of children for intradermal vaccine administration

Scientific Title

Study of skin properties of children for intradermal vaccine administration

Scientific Title:Acronym

Study of skin properties of children for intradermal vaccine administration

Region

Japan


Condition

Condition

Healty

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate skin properties including it thickness of 13-15 year-old children.

Basic objectives2

Others

Basic objectives -Others

property analysis

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skin cross section image examination(skin thickness)
Skin property (hardness, elasticity, viscosity)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Ultrasound echography
Skin property sensing

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

13 years-old <=

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

-Japanese
-A person 13-15 years of age
-a person without skin disease or any other histories infecting condition of skin
-Those who written informed consent is obtained from
-Healthy person

Key exclusion criteria

-A person who has any abnormality in the application site.
-A person who are deemed to have high risk to ultra-sound imaging examination.
-Those who are deemed inappropriate to participate in this study by doctor.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masaaki Mori

Organization

Yokohama City University Medical Center

Division name

Department of Pediatrics

Zip code


Address

4-57 Urafune-cho, Minami-ku, yokohama 232-0024, Japan

TEL

+81-45-261-5656

Email

mmorii@med.yokohama-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takuma Hara

Organization

Yokohama City University Medical Center

Division name

Department of Pediatrics

Zip code


Address

4-57 Urafune-cho, Minami-ku, yokohama 232-0024, Japan

TEL

+81-45-261-5656

Homepage URL


Email

mmorii@med.yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama City Univ, Medical Center

Institute

Department

Personal name



Funding Source

Organization

TERUMO CORPORATION

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 07 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 05 Month 23 Day

Date of IRB


Anticipated trial start date

2013 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 07 Month 16 Day

Last modified on

2014 Year 01 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013053


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name